APOL1 genotype and renal function of black living donors

Journal of the American Society of Nephrology

Volumn 29, Issue 4, 2018, Pages 1309-1316

  Doshi, Mona D ^a   Ortigosa Goggins, Mariella ^b   Garg, Amit X ^c   Li, Lihua ^c   Poggio, Emilio D ^d   Winkler, Cheryl A ^e   Kopp, Jeffrey B ^f  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Florida   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d LERNER RESEARCH INSTITUTE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN L1; CREATININE; APOL1 PROTEIN, HUMAN;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; HYPERTENSION; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; PRIORITY JOURNAL; ADVERSE EVENT; BLACK PERSON; CHRONIC KIDNEY FAILURE; DISEASE EXACERBATION; ETHNOLOGY; FAMILY; GENETIC PREDISPOSITION; GENETICS; GLOMERULUS FILTRATION RATE; KIDNEY; KIDNEY TRANSPLANTATION; MIDDLE AGED; NEPHRECTOMY; PHYSIOLOGY; RISK; TRANSPLANTATION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; APOLIPOPROTEIN L1; DISEASE PROGRESSION; FAMILY; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEPHRECTOMY; RISK; TISSUE AND ORGAN HARVESTING; TRANSPLANTS;

EID: 85044727830     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/asn.2017060658     Document Type: Article

References (26)

1. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S: High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 333: 333-336, 1995
2. Allen MB, Reese PP: Transforming living kidney donation with a comprehensive strategy. PLoS Med 13: e1001948, 2016
3. Doshi MD, Goggins MO, Li L, Garg AX: Medical outcomes in African American live kidney donors: A matched cohort study. Am J Transplant 13: 111-118, 2013
4. Muzaale AD, Massie AB, Wang MC, Montgomery RA, McBride MA, Wainright JL, et al: Risk of end-stage renal disease following live kidney donation. JAMA 311: 579-586, 2014
5. Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, et al: Long-term risks for kidney donors. Kidney Int 86: 162-167, 2014
6. Lentine KL, Schnitzler MA, Garg AX, Xiao H, Axelrod D, Tuttle-Newhall JE, et al: Race, relationship and renal diagnoses after kiving kidney donation. Transplantation 99: 1723-1729, 2015
7. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, et al: MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40: 1175-1184, 2008
8. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841-845, 2010
9. Ma L, Langefeld CD, Comeau ME, Bonomo JA, Rocco MV, Burkart JM, et al: APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with endstage renal disease. Kidney Int 90: 389-395, 2016
10. Zwang NA, Shetty A, Sustento-Reodica N, Gordon EJ, Leventhal J, Gallon L, et al: APOL1-associated end-stage renal disease in a living kidney transplant donor. Am J Transplant 16: 3568-3572, 2016
11. Kofman T, Audard V, Narjoz C, Gribouval O, Matignon M, Leibler C, et al: APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair. Am J Kidney Dis 63: 816-819, 2014
12. Locke JE, Sawinski D, Reed RD, Shelton B, MacLennan PA, Kumar V, et al: Apolipoprotein L1 and chronic kidney disease risk in young potential living kidney donors [published online ahead of print February 9, 2017]. Ann Surg 10.1097/SLA.0000000000002174
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999
14. Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, Froment A, et al: The genetic structure and history of Africans and African Americans. Science 324: 1035-1044, 2009
15. Freedman BI: APOL1 and nephropathy progression in populations of African ancestry. Semin Nephrol 33: 425-432, 2013
16. Grams ME, Rebholz CM, Chen Y, Rawlings AM, Estrella MM, Selvin E, et al: Race, APOL1 risk, and eGFR decline in the general population. J Am Soc Nephrol 27: 2842-2850, 2016
17. Ibrahim HN, Foley R, Tan L, Rogers T, Bailey RF, Guo H, et al: Long-term consequences of kidney donation. N Engl J Med 360: 459-469, 2009
18. Nogueira JM, Weir MR, Jacobs S, Haririan A, Breault D, Klassen D, et al: A study of renal outcomes in African American living kidney donors. Transplantation 88: 1371-1376, 2009
19. Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, et al: The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 11: 1025-1030, 2011
20. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, et al: Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Am J Transplant 15: 1615-1622, 2015
21. APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers: (Collaborative U01), Bethesda, MD, National Institutes of Health, 2017
22. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
23. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR Jr., et al: CARDIA: Study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 41: 1105-1116, 1988
24. Exam Components-All Years CARDIA, 2010. Available at: http://www.cardia.dopm.uab.edu/exam-materials2/exam-components.
25. Available at: http://www.mayo.edu/research/departments-divisions/department-health-sciences-research/division-biomedical-statisticsinformatics/software/locally-written-sas-macros#general.
26. Liu GF, Lu K, Mogg R, Mallick M, Mehrotra DV: Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? Stat Med 28: 2509-2530, 2009